---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-059761"
form_type: "8-K"
ticker: "ZVIA"
cik: "0001854139"
company_name: "Zevia PBC"
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T17:26:48.786719+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zevia Q3 net sales down 2.6% to $43.1M; net loss widens to $11.3M

## Summary
- Net sales $43.1M vs $44.2M YoY; unit volume down 8.2% to 3.3M cases.
- Gross margin improved to 45.4% (+2.1pp); net loss $11.3M ($0.16/sh) vs $9.2M loss.
- Adjusted EBITDA loss $9.1M vs $2.1M loss a year ago; selling & marketing costs surged.
- FY 2023 net sales guidance narrowed to $165M-$168M; Q4 projected $36M-$39M.
- Cash $38.5M, no debt; supply chain logistics challenges cited for volume decline.

## SEC filing metadata
- accession: 0000950170-23-059761
- form_type: 8-K
- ticker: ZVIA
- cik: 0001854139
- company_name: Zevia PBC
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/0000950170-23-059761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/zvia-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-059761
- JSON: https://secwatch.observer/filing/0000950170-23-059761.json
- Plain text: https://secwatch.observer/filing/0000950170-23-059761.txt

## Key facts
- Earnings Releases
  Zevia PBC reported third quarter ended September 30, 2023 results: revenue $43.1 million, net income $11.3 million, EPS $0.16 per diluted share.
  - Period: third quarter ended September 30, 2023
  - Revenue: $43.1 million
  - Net income: $11.3 million
  - EPS: $0.16 per diluted share
  - Result: reported results
  source text: Net sales decreased 2.6% year over year to $43.1 million • Unit volume decreased 8.2% year over year to 3.3 million equivalized cases • Gross profit margin was 45.4%, up 2.1 percentage points year over year • Net loss was $11.3 million, including $1.9 million of non-cash equity-based compensation expense • Adjusted EBITDA loss was $9.1 million (1) • Loss per share was $0.16 per diluted share to Zevia’s Class A Common stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854139/000095017023059761/0000950170-23-059761-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.